Dina George Lansey


If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Dina George Lansey is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 1 Similar Profiles
trabectedin Medicine & Life Sciences
Clinical Trials Medicine & Life Sciences
gemcitabine Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Patient Navigation Medicine & Life Sciences
Proxy Medicine & Life Sciences
Clinical Protocols Medicine & Life Sciences
Insurance Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2008 2018

Patient navigation and clinical trial participation: A randomized controlled trial design

Uveges, M. K., Lansey, D. G., Mbah, O., Gray, T., Sherden, L. & Wenzel, J., Dec 1 2018, In : Contemporary Clinical Trials Communications. 12, p. 98-102 5 p.

Research output: Contribution to journalArticle

Patient Navigation
Randomized Controlled Trials
Clinical Trials
Needs Assessment

Partnering around cancer clinical trials (PACCT): Study protocol for a randomized trial of a patient and physician communication intervention to increase minority accrual to prostate cancer clinical trials

Eggly, S., Hamel, L. M., Heath, E., Manning, M. A., Albrecht, T. L., Barton, E., Wojda, M., Foster, T., Carducci, M. A., Lansey, D. G., Wang, T., Abdallah, R., Abrahamian, N., Kim, S., Senft, N. & Penner, L. A., Dec 2 2017, In : BMC Cancer. 17, 1, 807.

Research output: Contribution to journalArticle

Clinical Protocols
Prostatic Neoplasms
Clinical Trials

The impact of insurance on access to cancer clinical trials at a comprehensive cancer center

Klamerus, J. F., Bruinooge, S. S., Ye, X., Klamerus, M. L., Damron, D., Lansey, D. G., Lowery, J. C., Diaz, L. A., Ford, J. G., Kanarek, N. F. & Rudin, C. M., Dec 15 2010, In : Clinical Cancer Research. 16, 24, p. 5997-6003 7 p.

Research output: Contribution to journalArticle

Clinical Trials
Insurance Coverage
Health Insurance

Phase I trial of weekly trabectedin (ET-743) and gemcitabine in patients with advanced solid tumors

Messersmith, W. A., Jimeno, A., Ettinger, D. S., Laheru, D., Brahmer, J., Lansey, D. G., Khan, Y., Donehower, R. C., Elsayed, Y., Zannikos, P. & Hidalgo, M., Dec 2008, In : Cancer Chemotherapy and Pharmacology. 63, 1, p. 181-188 8 p.

Research output: Contribution to journalArticle